MALTONI, ROBERTO
MALTONI, ROBERTO
Altri
Real-World Treatment Patterns and Survival in Patients with Advanced Non-Small Cell Lung Cancer: An Italian Retrospective Cohort Study
2026 Delmonte, A.; Gentili, N.; Roncadori, A.; Maltoni, R.; Danesi, V.; Hindocha, P.; Leal, C.; Oikonomou, S.; Mella, M.; Lay-Flurrie, S.; Emanuel, G.; Rault, C.; Glassberg, M. B.; Lee, A.; Yuan, Y.; Massa, I.
Hormonal Therapy For Endometriosis And The Risk Of Endometriosis-Associated Gynecologic Cancers: A Propensity Score-Adjusted Real-World Data Study
2025 Farolfi, A; Gianni, C; Palleschi, M; Casadei, C; Montanari, D; Miserocchi, G; Ibarburu, Gh; Gentili, N; Mariotti, M; Testoni, S; Di Menna, G; Rusconi, F; Andalò, A; Merloni, F; Sirico, M; Maltoni, R; Cecconetto, L; Sarti, S; Musolino, A
ROLE OF HPV VACCINATION AFTER CARCINOMA IN SITU OF CERVIX UTERI (CIN) IN REAL-WORLD PATIENTS
2025 Farolfi, A; Petracci, E; Casadei, C; Paoletti, E; Gianni, C; Palleschi, M; Sabbioni, S; Montanari, D; Miserocchi, G; Gentili, N; Mariotti, M; Testoni, S; Di Menna, G; Rusconi, F; Andalò, A; Merloni, F; Carlini, A; Sirico, M; Maltoni, R; Serra, O; Cecconetto, L; Sarti, S; Muscolino, A
HDAC6 as a Prognostic Factor and Druggable Target in HER2-Positive Breast Cancer
2024 Cortesi, M.; Bravaccini, S.; Ravaioli, S.; Petracci, E.; Angeli, D.; Tumedei, M. M.; Balzi, W.; Pirini, F.; Zanoni, M.; Possanzini, P.; Rocca, A.; Palleschi, M.; Ulivi, P.; Martinelli, G.; Maltoni, R.
Local treatment for oligoprogressive metastatic sites of breast cancer: efficacy, toxicities and future perspectives
2024 Merloni, F.; Palleschi, M.; Gianni, C.; Sirico, M.; Serra, R.; Casadei, C.; Sarti, S.; Cecconetto, L.; Di Menna, G.; Mariotti, M.; Maltoni, R.; Montanari, D.; Romeo, A.; De Giorgi, U.
Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab
2022 Palleschi M.; Prochowski Iamurri A.; Scarpi E.; Mariotti M.; Maltoni R.; Mannozzi F.; Barone D.; Paganelli G.; Casi M.; Giampalma E.; De Giorgi U.; Rocca A.
Circulating tumor cells as a tool to untangle the breast cancer heterogeneity issue
2021 Rossi T.; Gallerani G.; Martinelli G.; Maltoni R.; Fabbri F.
Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-stage Breast Cancer?
2020 Maltoni R.; Palleschi M.; Altini M.; Massa I.; Balzi W.; Ravaioli S.; Tumedei M.M.; Rocca A.; Bravaccini S.
Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer
2020 Maltoni R.; Palleschi M.; Ravaioli S.; Tumedei M.M.; Rocca A.; Melegari E.; Altini M.; Puccetti M.; Manunta S.; Bravaccini S.
Immunotherapy: The end of the "dark age" for metastatic triple-negative breast cancer?
2020 Palleschi M.; Maltoni R.; Sarti S.; Melegari E.; Bravaccini S.; Rocca A.
Ki67 and PR in patients treated with CDK4/6 Inhibitors: A real-world experience
2020 Palleschi M.; Maltoni R.; Ravaioli S.; Vagheggini A.; Mannozzi F.; Fanini F.; Pirini F.; Tumedei M.M.; Barzotti E.; Cecconetto L.; Sarti S.; Manunta S.; Possanzini P.; Fedeli A.; Curcio A.; Altini M.; de Giorgi U.; Rocca A.; Bravaccini S.
Are there differences in androgen receptor expression in invasive breast cancer in African (Tanzanian) population in comparison with the Caucasian (Italian) population?
2018 Bravaccini S.; Ravaioli S.; Amadori D.; Scarpi E.; Puccetti M.; Rocca A.; Tumedei M.M.; Masalu N.; Kahima J.; Pangan A.; Faustine L.; Farolfi A.; Maltoni R.; Bonafe M.; Serra P.; Bronte G.
Progress with palbociclib in breast cancer: Latest evidence and clinical considerations
2017 Rocca A.; Schirone A.; Maltoni R.; Bravaccini S.; Cecconetto L.; Farolfi A.; Bronte G.; Andreis D.
Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy
2016 Gennari A.; Amadori D.; Scarpi E.; Farolfi A.; Paradiso A.; Mangia A.; Biglia N.; Gianni L.; Tienghi A.; Rocca A.; Maltoni R.; Antonucci G.; Bruzzi P.; Nanni O.
Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer
2015 Rocca A.; Farolfi A.; Maltoni R.; Carretta E.; Melegari E.; Ferrario C.; Cecconetto L.; Sarti S.; Schirone A.; Fedeli A.; Andreis D.; Pietri E.; Ibrahim T.; Montalto E.; Amadori D.
Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy
2015 Rocca A.; Andreis D.; Fedeli A.; Maltoni R.; Sarti S.; Cecconetto L.; Pietri E.; Schirone A.; Bravaccini S.; Serra P.; Farolfi A.; Amadori D.
Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer
2015 Farolfi A.; Scarpi E.; Rocca A.; Mangia A.; Biglia N.; Gianni L.; Tienghi A.; Valerio M.R.; Gasparini G.; Amaducci L.; Faedi M.; Baldini E.; Rubagotti A.; Maltoni R.; Paradiso A.; Amadori D.
Trastuzumab-induced cardiotoxicity in early breast cancer patients: A retrospective study of possible risk and protective factors
2013 Farolfi A.; Melegari E.; Aquilina M.; Scarpi E.; Ibrahim T.; Maltoni R.; Sarti S.; Cecconetto L.; Pietri E.; Ferrario C.; Fedeli A.; Faedi M.; Nanni O.; Frassineti G.L.; Amadori D.; Rocca A.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Real-World Treatment Patterns and Survival in Patients with Advanced Non-Small Cell Lung Cancer: An Italian Retrospective Cohort Study | Delmonte, A.; Gentili, N.; Roncadori, A.; Maltoni, R.; Danesi, V.; Hindocha, P.; Leal, C.; Oikono...mou, S.; Mella, M.; Lay-Flurrie, S.; Emanuel, G.; Rault, C.; Glassberg, M. B.; Lee, A.; Yuan, Y.; Massa, I. | 2026-01-01 | CANCERS | - | 1.01 Articolo in rivista | - |
| Hormonal Therapy For Endometriosis And The Risk Of Endometriosis-Associated Gynecologic Cancers: A Propensity Score-Adjusted Real-World Data Study | Farolfi, A; Gianni, C; Palleschi, M; Casadei, C; Montanari, D; Miserocchi, G; Ibarburu, Gh; Genti...li, N; Mariotti, M; Testoni, S; Di Menna, G; Rusconi, F; Andalò, A; Merloni, F; Sirico, M; Maltoni, R; Cecconetto, L; Sarti, S; Musolino, A | 2025-01-01 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | - | 1.01 Articolo in rivista | - |
| ROLE OF HPV VACCINATION AFTER CARCINOMA IN SITU OF CERVIX UTERI (CIN) IN REAL-WORLD PATIENTS | Farolfi, A; Petracci, E; Casadei, C; Paoletti, E; Gianni, C; Palleschi, M; Sabbioni, S; Montanari..., D; Miserocchi, G; Gentili, N; Mariotti, M; Testoni, S; Di Menna, G; Rusconi, F; Andalò, A; Merloni, F; Carlini, A; Sirico, M; Maltoni, R; Serra, O; Cecconetto, L; Sarti, S; Muscolino, A | 2025-01-01 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | - | 1.06 Abstract in rivista | - |
| HDAC6 as a Prognostic Factor and Druggable Target in HER2-Positive Breast Cancer | Cortesi, M.; Bravaccini, S.; Ravaioli, S.; Petracci, E.; Angeli, D.; Tumedei, M. M.; Balzi, W.; P...irini, F.; Zanoni, M.; Possanzini, P.; Rocca, A.; Palleschi, M.; Ulivi, P.; Martinelli, G.; Maltoni, R. | 2024-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-16-03752.pdf; cancers-16-03752-s001.zip |
| Local treatment for oligoprogressive metastatic sites of breast cancer: efficacy, toxicities and future perspectives | Merloni, F.; Palleschi, M.; Gianni, C.; Sirico, M.; Serra, R.; Casadei, C.; Sarti, S.; Cecconetto..., L.; Di Menna, G.; Mariotti, M.; Maltoni, R.; Montanari, D.; Romeo, A.; De Giorgi, U. | 2024-01-01 | CLINICAL & EXPERIMENTAL METASTASIS | - | 1.01 Articolo in rivista | - |
| Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab | Palleschi M.; Prochowski Iamurri A.; Scarpi E.; Mariotti M.; Maltoni R.; Mannozzi F.; Barone D.; ...Paganelli G.; Casi M.; Giampalma E.; De Giorgi U.; Rocca A. | 2022-01-01 | SCIENTIFIC REPORTS | - | 1.01 Articolo in rivista | - |
| Circulating tumor cells as a tool to untangle the breast cancer heterogeneity issue | Rossi T.; Gallerani G.; Martinelli G.; Maltoni R.; Fabbri F. | 2021-01-01 | BIOMEDICINES | - | 1.03 Recensione in rivista | biomedicines-09-01242-v2 (3).pdf |
| Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-stage Breast Cancer? | Maltoni R.; Palleschi M.; Altini M.; Massa I.; Balzi W.; Ravaioli S.; Tumedei M.M.; Rocca A.; Bra...vaccini S. | 2020-01-01 | CLINICAL BREAST CANCER | - | 1.04 Replica / breve intervento (e simili) | - |
| Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer | Maltoni R.; Palleschi M.; Ravaioli S.; Tumedei M.M.; Rocca A.; Melegari E.; Altini M.; Puccetti M....; Manunta S.; Bravaccini S. | 2020-01-01 | CELL TRANSPLANTATION | - | 1.01 Articolo in rivista | maltoni-et-al-2020.pdf |
| Immunotherapy: The end of the "dark age" for metastatic triple-negative breast cancer? | Palleschi M.; Maltoni R.; Sarti S.; Melegari E.; Bravaccini S.; Rocca A. | 2020-01-01 | THE BREAST JOURNAL | - | 1.04 Replica / breve intervento (e simili) | - |
| Ki67 and PR in patients treated with CDK4/6 Inhibitors: A real-world experience | Palleschi M.; Maltoni R.; Ravaioli S.; Vagheggini A.; Mannozzi F.; Fanini F.; Pirini F.; Tumedei ...M.M.; Barzotti E.; Cecconetto L.; Sarti S.; Manunta S.; Possanzini P.; Fedeli A.; Curcio A.; Altini M.; de Giorgi U.; Rocca A.; Bravaccini S. | 2020-01-01 | DIAGNOSTICS | - | 1.01 Articolo in rivista | Ki67 and PR in Patients Treated with CDK4 6.pdf |
| Are there differences in androgen receptor expression in invasive breast cancer in African (Tanzanian) population in comparison with the Caucasian (Italian) population? | Bravaccini S.; Ravaioli S.; Amadori D.; Scarpi E.; Puccetti M.; Rocca A.; Tumedei M.M.; Masalu N....; Kahima J.; Pangan A.; Faustine L.; Farolfi A.; Maltoni R.; Bonafe M.; Serra P.; Bronte G. | 2018-01-01 | FRONTIERS IN ENDOCRINOLOGY | - | 1.01 Articolo in rivista | - |
| Progress with palbociclib in breast cancer: Latest evidence and clinical considerations | Rocca A.; Schirone A.; Maltoni R.; Bravaccini S.; Cecconetto L.; Farolfi A.; Bronte G.; Andreis D. | 2017-01-01 | THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | - | 1.03 Recensione in rivista | - |
| Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy | Gennari A.; Amadori D.; Scarpi E.; Farolfi A.; Paradiso A.; Mangia A.; Biglia N.; Gianni L.; Tien...ghi A.; Rocca A.; Maltoni R.; Antonucci G.; Bruzzi P.; Nanni O. | 2016-01-01 | BREAST CANCER RESEARCH AND TREATMENT | - | 1.01 Articolo in rivista | - |
| Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer | Rocca A.; Farolfi A.; Maltoni R.; Carretta E.; Melegari E.; Ferrario C.; Cecconetto L.; Sarti S.;... Schirone A.; Fedeli A.; Andreis D.; Pietri E.; Ibrahim T.; Montalto E.; Amadori D. | 2015-01-01 | BREAST CANCER RESEARCH AND TREATMENT | - | 1.01 Articolo in rivista | - |
| Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy | Rocca A.; Andreis D.; Fedeli A.; Maltoni R.; Sarti S.; Cecconetto L.; Pietri E.; Schirone A.; Bra...vaccini S.; Serra P.; Farolfi A.; Amadori D. | 2015-01-01 | EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | - | 1.03 Recensione in rivista | - |
| Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancer | Farolfi A.; Scarpi E.; Rocca A.; Mangia A.; Biglia N.; Gianni L.; Tienghi A.; Valerio M.R.; Gaspa...rini G.; Amaducci L.; Faedi M.; Baldini E.; Rubagotti A.; Maltoni R.; Paradiso A.; Amadori D. | 2015-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Trastuzumab-induced cardiotoxicity in early breast cancer patients: A retrospective study of possible risk and protective factors | Farolfi A.; Melegari E.; Aquilina M.; Scarpi E.; Ibrahim T.; Maltoni R.; Sarti S.; Cecconetto L.;... Pietri E.; Ferrario C.; Fedeli A.; Faedi M.; Nanni O.; Frassineti G.L.; Amadori D.; Rocca A. | 2013-01-01 | HEART | - | 1.01 Articolo in rivista | - |